Abstract
The key-points of the physiopathological treatment of chronic pneumogenous respiratory insufficiency are: correction of distribution defects, suitable local adjustment of the ventilation: perfusion ratio, and correction of obstacles to alveolocapillary diffusion. Many drugs can be used to obtain these results; bronchodilators, vasoactive drugs, cortisones, cardiokinetics, antibiotics, analeptics. Reference is also made to oxygen therapy, depletion management (bloodletting and-or diuretics, and their possible mechanisms. Lastly, attention is given to disturbances, in acid-base equilibrium in chronic respiratory insufficiency and their correction.
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use
-
Adrenergic alpha-Antagonists / therapeutic use
-
Adrenergic beta-Agonists / therapeutic use
-
Anti-Bacterial Agents / therapeutic use
-
Atropine / therapeutic use
-
Bloodletting
-
Bronchodilator Agents / therapeutic use
-
Chronic Disease
-
Cromolyn Sodium / therapeutic use
-
Expectorants / therapeutic use
-
Humans
-
Oxygen Inhalation Therapy
-
Prostaglandins E, Synthetic / therapeutic use
-
Respiratory Insufficiency / drug therapy
-
Respiratory Insufficiency / etiology
-
Respiratory Insufficiency / therapy*
-
Sympathomimetics / therapeutic use
-
Water-Electrolyte Balance
Substances
-
Adrenal Cortex Hormones
-
Adrenergic alpha-Antagonists
-
Adrenergic beta-Agonists
-
Anti-Bacterial Agents
-
Bronchodilator Agents
-
Expectorants
-
Prostaglandins E, Synthetic
-
Sympathomimetics
-
Atropine
-
Cromolyn Sodium